Back to Blog

Gut Cancer Foundation appoint new Executive Officer

The New Zealand Gut Cancer Foundation (GCF) are pleased to announce the appointment of new Executive Officer, Liam Willis, to help fund clinical research for kiwis affected by gut cancers and drive important awareness of this group of cancers among those at risk. Press Release - New Executive Officer appointment ...

Professor Peter Shepherd awarded funding

Ted and Mollie Carr & Estate of Ernest Davis grant has been awarded to Professor Peter Shepherd and Dr Khanh Tran, Auckland Cancer Society Research Centre and the Department of Molecular Medicine at the University of Auckland.   Professor Peter Shepherd and his team at the University of Auckland, have been awarded $50,000 for a second year to study a form of colorectal cancer which is difficult to treat normally. A drug combination used to treat melonoma will be trialed in the laborato...

ACTICCA Trial

GCF has funded Dr Amanda Ashley and her team at Auckland Hospital,three patients to go onto this valuable trial to the value of $23,741. ACTICCA-1 is a randomised, controlled, two stage, multicentre Phase III trial comparing gemcitabine+ cisplatin with standard of care (capecitabine) after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma. Cholangiocarcinoma is diagnosed in approximately 80 people every year in New Zealand. In half of these people curative...

Run, walk.....the Auckland Marathon

Join the Gutsy Team to help save lives from Gut Cancers! Get the family together and make it a great day. Full Marathon Half Marathon 12k Traverse 5k Challenge 2k Kids Marathon Exercise helps prevent gut cancers! Register today through here...

TV interviews

View our latest TV interviews TV 3  Newshub click  here TV 3 AM show click here TV 3 The Cafe show click here...

THYmine 2 Research

GCF has funded Dr Nuala Helsby and her team at the University of Auckland, a year's part time salary for a clinical trial manager to support the following research.  THYmine2 is an observational study to assess whether the thymine loading test can prospectively categorise patients who cannot tolerate 5-FU treatment (e.g. FOLFOX, CapeOx, FLOX). This treatment is commonly used in GI and breast cancer treatment. Reactions occur in approximately 10% of patients and can result in life threa...

Farewell Grant Baker, welcome Tim Miles

Farewell Grant Baker, welcome Tim Miles. We have said goodbye to Grant Baker after 10 years service to GICI then GCF. He has been instrumental in our growing into a progressive and credible cancer research charity. Tim Miles has been appointed as the new chairman and he has a strong background in the digital industry including Vodafone in UK and NZ as CEO as well as a director for other major companies. Welcome Tim!...

GastroFest Raises $75,000 for Gut Cancer Research

GastroFest was a night of fine food, wine and entertainment! We raised $75,000 for gut cancer research and awareness.  Special thanks to our Platinum sponsors Qatar Airways NZ and Turners Automotive Ltd....

New Detailed Booklet

Our new detailed booklet provides facts about all the gut cancers, helpful website links and support for those living with a gut cancer. You can access this online, see above link, or order copies from us through info@gutcancer.org.nz...

New research grant awarded

Professor Peter Shepherd, Dr Khanh Tran and their team at the University of Auckland, have been awarded $50,000 for one year to study a form of colorectal cancer which is difficult to treat normally. A drug combination used to treat melonoma will be trialed in the laboratory as a pre-clinical experiment to determine if there is any tumour response using the drugs vemurafenib and axitinib.  This funding is thanks to the Ted and Mollie Carr Fund through Perpetual...

Community Power

Raise funds for GCF by just switching on your light switch! Your power bill will not change and each individual household enrolled will give us $100 to $150 a year.  Register click here...

Fellowship open

  Subject: Call for Applications: Part time 0.3-0.5 FTE Gastro-Intestinal (GI) Cancer Clinical Research Fellowship Subject title: GICI NZ: Call for Applications – Part time 0.3-0.5 FTE GI Cancer Clinical Research Fellowship The GI Cancer Institute NZ is calling for applications for: Part time GI Cancer Clinical Fellowship The GI Cancer Institute NZ offers one part time 0.3-0.5 FTE GI Cancer Clinical Research Fellowship award each year supported by the Hugh Green Foundation. The Fellowship...

Award for Professor Michael Findlay

Our own Professor Michael Findlay was awarded the John Zalcberg OAM award at the AGITG conference in Cairns for his services to GI cancer in Australia and New Zealand. Pictured with the man himself and our new brand / logo. Very proud moment for NZ team. Congratulations Mike!!...

Koru Hideaway Dine In

Koru Hideaway and Lisa Toi hosted a gorgeous Dine In. Pictures can be found through here   You can host your own Dine In, just go to our fundraising page for more information. Any size, any shape.....all are important and every dollar counts....

Bowel Cancer Screening starts

Congratulations to the Ministry of Health for starting the National Bowel Screening Programme. Watch the latest Sunday programme here. The first screening programme for men and women. It is for ages 60 to 74 years. Just over 300 people are diagnosed with bowel cancer between the ages of 50 and 59 years. So keep aware of those symptoms such as bleeding from the bowel, unexplained weight loss and anaemia. Demand a colonoscopy if these occur!...

Thank you

Thanks Turners Cars for donating the Hyundai i35 SUV to GICI. It is going to make such a difference to our visibility in the community. Can't wait to get it signed with the new brand!...

New Director, Lisa Toi

Lisa Toi has 25 years commercial/strategic experience across range of industries and global organisations including 21 years in the NZ healthcare sector. She is currently a consultant providing strategic, stakeholder engagement consulting and project management resource to a range of public and private organisations engaging in consumer-centred digital health or behaviour change programmes.  Her passion for gastro-intestinal cancers is due to her mother dying from bowel and liver cancer as ...

Dr YK Ip

Dr YK Ip tells his story of diagnosis and journey with rectal cancer Despite being a doctor he had to battle the health system for a year before his symptoms were confirmed as cancer!  He has an important message to share....

GICI Fellowship awarded for 2017

Dr Janet Rhodes is a surgical registrar trainee who has been awarded $50,000, thanks to the Hugh Green Foundation, to take time out of her clinical work to complete her PhD. Her supervisors are Professor John McCall and Dr Roslyn Kemp who are well known to GICI. Her words below describe the importance of her work. "Colorectal cancer (CRC) is the second highest cause of cancer death in New Zealand. Some patients require surgery alone, while others need chemotherapy to complete treatment. It is no...

GICI welcomes Dr Iain Ward

Dr Iain Ward is a radiation oncologist at the Canterbury Regional Cancer and Haematology Service, specialising in the treatment of gastrointestinal cancer, head and neck cancer and soft tissue sarcoma.   After graduating from the University of Otago, he trained in medical oncology at Christchurch Hospital and in radiation oncology at the Peter MacCallum Cancer Centre in Melbourne.  This was followed by fellowships in gastrointestinal cancer and in head and neck cancer at the Princ...

GICI funds Research.

GICI is also very pleased to announce an award of $50,000, thanks to the generosity of the Hugh Green Foundation, to Dr Rachel Purcell of the University of Otago. New Zealand has one of the highest rates of colorectal cancer (CRC) in the world. Dr Purcell and her team will be looking at molecular subtyping and the gut flora in relation to colorectal cancers asking the following two questions. i) Can molecular subtyping of Colo Rectal Cancer lead to a more personalised approach to treatment and i...

GICI funds Research.

Major AnnouncementGICI funds three new trials!! $50,000 has been awarded to Dr Roslyn Kemp of the University of Otago. In colorectal cancer, a strong immune response within the tumour is associated with a good outcome for patients. Dr Kemp will validate this finding, for the first time, in New Zealand patients. She will also use a new technology to characterize these immune cells to determine their mechanisms of action. This is vital research bringing colorectal cancer up to the latest in immuno...

INTEGRATE ll funded

GICI part funds patients onto clinical trial INTEGRATE ll for recruitment for radiology and laboratory requirements.INTEGRATE ll is a Randomised III Double-Blind Placebo-Controlled Study of regorafenib in Advanced Gastro-Oesophageal Cancer (AGOC) which will be conducted in Australia, New Zealand, Korea, Japan, Taiwan, Canada and the USA.There currently exist few effective treatment options for patients with Advanced Gastro-Oesophageal Cancer (AGOC) that has returned after surgery or where it is ...

GastroFest

A decadent and interactive charity dining experience for a good cause!  Dine with some of New Zealand’s top chefs who will each produce a course to tempt the most discerning palate while enjoying matching wine and craft beer. When 3rd November 2016, 6.30pm‑ 10.30pm  Where Little Wolf,  5 Water Street, Grafton / Mt Eden  Price $150 per ticket,  Table of 10: $1,400 Purchase tickets here...

Ambassador

GICI welcomes Anne Hargreaves to the organisation as our latest Ambassador. Wife of founding chairman, Paul Hargreaves, Anne has been committed to GICI since the beginning and has attended many of our trans-Tasman conferences.    The importance of the role of partners in supporting patients and providing the encouragement and holistic environment in which to face the challenges of treatment is, she feels, often overlooked.  Anne, who is a Justice of the Peace, with a BA from Cante...